News | January 06, 2008

Cook Medical Pays Cardica $2 Million for Milestones

January 7, 2008 - Cardica Inc. received nearly $2 million in payments from Cook Medical (Cook) for reaching milestones pursuant to its development agreements with Cook, including a vascular closure device collaboration agreement and initial development milestone for a device to repair heart defects.

Cardica received the fourth and final milestone payment of $500,000 for the delivery of the Cook Vascular Closure Device (CVCD), an automated system designed to close access openings in femoral arteries after interventional vascular procedures. Cook also paid $1.3 million to Cardica for the successful completion of the first phase of design and development of a specialized device designed to close patent foramen ovales (PFO), genetic heart defects.

Cardica also received a payment of $180,000 from Cook for the initial purchase of parts to build a specific number of these vascular closure devices for commercial use.

Under the agreement for the CVCD, Cardica has received a total of $2.0 million in milestone payments and has expanded this collaboration to include a second product in the vascular closure device product line. Similarly, under the agreement for the PFO closure device, Cardica has received to date $2.15 million in fees and milestone payments and may receive an additional approximately $1.4 million in development milestone payments beyond the $1.3 million announced today. With both products, Cardica is also entitled to receive royalties on any future worldwide sales by Cook, and Cook has exclusive worldwide commercialization and marketing rights.

For more information: www.cookmedical.com and www.cardica.com

Related Content

Data was positive from the Watchman Left Atrial Appendage Closure (LAAC) Device from the EWOLUTION registry
News | Atrial Fibrillation| May 30, 2017
May 30, 2017 — Data was positive for safety and efficacy rates of the Watchman Left Atrial Appendage Closure (LAAC) D
atricure atriclip, LAA occlusion, acc17

The AtriCure Atriclip surgical LAA occlusion device. It loops over the LAA on the outside of the heart and clips it off from the rest of the heart to prevent the formation of clots.

Feature | Left Atrial Appendage (LAA) Occluders| March 29, 2017
March 29, 2017 — For patients with...
Dee Dee Wang, Henry Ford Hospital, 3D printing for cardiology, 3-D

Dr. Dee Dee Wang with part of Henry Ford Hospital's collection of 3-D printed hearts used for education and to preplan structural heart procedures.

Feature | 3-D Printing| March 03, 2017
March 3, 2017 — A Henry Ford Hospital study found a 100 percent success rate in left atrial appendage (LAA) occlusion
University of Alabama at Birmingham, Amplatzer PFO Occluder, first implementation
News | Structural Heart Occluders| February 15, 2017
Doctors at the University of Alabama at Birmingham have implemented the first U.S. Food and Drug Administration (FDA)-...
Amplatzer PFO Occluder, St. Jude Medical, Baylor Heart and Vascular Services, Fort Worth, Texas, first patients
News | Structural Heart Occluders| February 01, 2017
Baylor Heart and Vascular Services at Fort Worth in November became the first program in Texas to implant the Amplatzer...
NCDR, ACC, JACC, American College of Cardiology, national trends, heart disease treatments, trends in cardiovascular care
News | Cath Lab| January 23, 2017
January 23, 2017 — Over 93 percent of heart attack patients are receiving stents within the guideline-recommended thr
Vascular Solutions, Teleflex
Feature | December 07, 2016
December 7, 2016 — Teleflex Inc. and Vascular Solutions Inc.
RESPECT trial, Amplatzer PFO Occluder, St. Jude Medical, TCT 2016
News | Structural Heart Occluders| November 02, 2016
St. Jude Medical Inc. announced the long-term data from RESPECT, a landmark trial, during a First Report session at the...
St. Jude Medical, Amplatzer PFO Occluder, FDA approval, U.S. launch
Technology | Structural Heart Occluders| November 02, 2016
St. Jude Medical Inc. announced this week the U.S. Food and Drug Administration (FDA) approval and launch of the...
Overlay Init